Patrick Trojer, Chief Scientific Officer at CONSTELLATION PHARMACEUTICALS INC (CNST), sold 92,284 shares at $25.06 ($2.3M) on 2019-11-06, disclosed to the SEC on 2019-11-08.
Open-market sale of $2.3M CNST by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 11,535 | $231K | 10.0% |
| 2 | $20.01 | 11,535 | $231K | 10.0% |
| 3 | $25.06 | 23,072 | $578K | 25.0% |
| 4 | $25.06 | 23,072 | $578K | 25.0% |
| 5 | $30.16 | 11,535 | $348K | 15.0% |
| 6 | $30.16 | 11,535 |
| $348K |
| 15.0% |
| Total | $25.07 avg | 92,284 | $2.3M | 100% |
| Filing → |
| CNST | SELL | 2019-10-24 | $159K | — | Filing → |